Maria Elena Bottazzi and Peter Hotez and in-licensed from BCM Ventures, Baylor College of Medicine’s integrated commercialization team, to Hyderabad-based vaccine and pharmaceutical company Biological E.
The initial construct and production process of the vaccine antigen was developed at Texas Children’s Hospital CVD, led by co-directors Drs.
HOUSTON, TX (December 28, 2021) – Texas Children’s Hospital and Baylor College of Medicine announced today that CORBEVAX ™, a protein sub-unit COVID-19 Vaccine, whose technology was created and engineered at its Center for Vaccine Development (CVD), has received Emergency Use Authorization (EUA) approval from the Drugs Controller General of India (DCGI) to launch in India with other underserved countries to follow.ĭubbed “The World’s COVID-19 Vaccine”, it uses a traditional recombinant protein-based technology that will enable its production at large scales making it widely accessible to inoculate the global population. A prototype RBD219 N1 vaccine is entering scale-up process development Multivalent Anthelmintic Vaccine Discovery A panhelmintic vaccine to prevent ascariasis (roundworm) and trichuris (whipworm), soil-transmitted helminths afflicting hundreds of millions of people around the world.Mass Distribution of “The World’s COVID-19 Vaccine” to be Deployed to India with Other Underserved Countries to Follow SARS Vaccine A new vaccine to prevent severe acute respiratory syndrome (SARS). Chagas Disease and Leishmaniasis Vaccine A project for the selection and discovery of antigens appropriate to advance into the development process of new vaccines to combat Chagas disease (American trypanosomiasis) and leishmaniasis. Our vaccine is entering phase 1 clinical trials. Schistosomiasis Vaccine Schistosomiasis afflicts over 200 million people around the globe and is the deadliest disease among the seven most prevalent NTDs, killing an estimated 280,000 people annually. Vaccine currently in phase 1 clinical trials in Brazil and Gabon. Projects Human Hookworm Vaccine Development of a vaccine for the more than 400 million people suffering from hookworm infection in the world today. New Haven, Connecticut United States Professional Interests Houston, Texas United States Health Policy ScholarĬenter for Medical Ethics and Health PolicyĮducation M.D.
Houston, Texas United States Fellow in Disease and Poverty
Houston, Texas United States Founding Editor in Chief Texas Children's Hospital Center for Vaccine Development Houston, Texas United States Endowed Chair in Tropical Pediatrics Email Positions Dean for the National School of Tropical Medicineĭepartments of Pediatrics and Molecular Virology & Microbiology
0 kommentar(er)
